64 related articles for article (PubMed ID: 18945552)
21. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
[TBL] [Abstract][Full Text] [Related]
22. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
23. Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology.
Salit IE; Tinmouth J; Chong S; Raboud J; Diong C; Su D; Sano M; Lytwyn A; Chapman W; Mahony J
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1986-92. PubMed ID: 19567510
[TBL] [Abstract][Full Text] [Related]
24. Demographic and risk factors in patients with head and neck tumors.
Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
[TBL] [Abstract][Full Text] [Related]
25. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
26. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
[TBL] [Abstract][Full Text] [Related]
27. Screening for molecular markers of cervical papillomavirus infection: overview of methods and their clinical implications.
Dehn D; Taylor A; Fischer TJ; Malinowski DP; Shroyer KR
Methods Mol Biol; 2009; 511():297-310. PubMed ID: 19347302
[TBL] [Abstract][Full Text] [Related]
28. Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions.
Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
J Virol Methods; 2009 Jun; 158(1-2):180-3. PubMed ID: 19187786
[TBL] [Abstract][Full Text] [Related]
29. HPV and cervical cancer: updates on an established relationship.
Subramanya D; Grivas PD
Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
[TBL] [Abstract][Full Text] [Related]
31. Assessing the HPV vaccine: researchers confront complex interplay of factors.
Tuma RS
J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636
[No Abstract] [Full Text] [Related]
32. HPV induced triple neoplasms: a case report.
Visconti V; Antonilli M; Bellati F; Napoletano C; French D; Benedetti Panici P; Nuti M
Am J Obstet Gynecol; 2009 Aug; 201(2):e9-e12. PubMed ID: 19646562
[TBL] [Abstract][Full Text] [Related]
33. Is a novel human retrovirus associated with prostate cancer and chronic fatigue syndrome?
Bannert N
Future Microbiol; 2010 May; 5(5):689-91. PubMed ID: 20441540
[No Abstract] [Full Text] [Related]
34. Molecular genetics and epidemiology of prostate carcinoma.
Ruijter E; van de Kaa C; Miller G; Ruiter D; Debruyne F; Schalken J
Endocr Rev; 1999 Feb; 20(1):22-45. PubMed ID: 10047972
[No Abstract] [Full Text] [Related]
35. Virology. No meeting of minds on XMRV's role in chronic fatigue, cancer.
Kaiser J
Science; 2010 Sep; 329(5998):1454. PubMed ID: 20847240
[No Abstract] [Full Text] [Related]
36. New virus linked to prostate cancer.
Hampton T
JAMA; 2006 Apr; 295(13):1503. PubMed ID: 16595746
[No Abstract] [Full Text] [Related]
37. Human papillomavirus antibody and risk of prostate cancer.
Hisada M; Rabkin CS; Strickler HD; Wright WE; Christianson RE; van den Berg BJ
JAMA; 2000 Jan; 283(3):340-1. PubMed ID: 10647795
[No Abstract] [Full Text] [Related]
38. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis.
Lin Y; Mao Q; Zheng X; Yang K; Chen H; Zhou C; Xie L
Ir J Med Sci; 2011 Jun; 180(2):497-503. PubMed ID: 21400096
[TBL] [Abstract][Full Text] [Related]
39. Is prostate cancer an HPV-associated lesion?
Kong DB; Zheng XY; Xie LP; Sima N
Med Hypotheses; 2009 Jan; 72(1):101. PubMed ID: 18945552
[No Abstract] [Full Text] [Related]
40. Involvement of human papillomavirus infections in prostate cancer progression.
Al Moustafa AE
Med Hypotheses; 2008 Aug; 71(2):209-11. PubMed ID: 18468811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
